Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00081965 · ClinicalTrials.gov registry record · NA
Acupuncture in Treating Hot Flashes in Women With Breast Cancer
A NA study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00081965: Completed NA study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00081965 is a NA study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00081965, a NA study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
RATIONALE: Acupuncture may help relieve hot flashes in women with breast cancer. It is not yet known whether acupuncture is more effective than a placebo in treating hot flashes in women with breast cancer PURPOSE: This randomized clinical trial is studying acupuncture to see how well it works compared to a placebo in treating hot flashes in women with breast cancer.
Interventions
- PROCEDURE management of therapy complications
- PROCEDURE acupuncture therapy
- PROCEDURE hot flashes attenuation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Est. Completion | 2007-05 |
| Phase | NA |
What the finished NCT00081965 record still lists
NCT00081965 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 3 interventions - of which management of therapy complications is the first listed.
NCT00081965 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00081965 about?
NCT00081965 is a clinical study titled "Acupuncture in Treating Hot Flashes in Women With Breast Cancer". RATIONALE: Acupuncture may help relieve hot flashes in women with breast cancer. It is not yet known whether acupuncture is more effective than a placebo in treating hot flashes in women with breast cancer PURPOSE: This randomized clinical trial is studying acupuncture to see how well it works comp...
What is the current status of trial NCT00081965?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. Estimated completion is 2007-05.
What interventions are being tested in trial NCT00081965?
The interventions under investigation include: management of therapy complications (PROCEDURE), acupuncture therapy (PROCEDURE), hot flashes attenuation (PROCEDURE).
Who is sponsoring clinical trial NCT00081965?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00081965's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts